УДК: 615.38:616-036.21-082
DOI: 10.26212/2227-1937.2023.79.70.005
Received: 1 june 2023/ Accepted: 29 june 2023 / Published online: 01july 2023
Maral A. Yerdenova1, https://orcid.org/0000 – 0002 – 4375-9506
Aigulsum K. Izekenova1, https://orcid.org/0000-0003 – 3850-8689
Аkbope K. Myrkassymova1, https://orcid.org/0000-0002-2134-2494
Gaukhar A. Mergenova1,2, https://orcid.org/0000-0003-4702-1944
1Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
2Global Health Research Center of Central Asia, Almaty, Kazakhstan
SCIENTIFICALLY SUBSTANTIATED APPROACHES TO THE ORGANIZATION OF HEMATOLOGICAL CARE IN THE CONTEXT OF THE COVID-19 PANDEMIC: A COMPREHENSIVE REVIEW
Resume: The COVID-19 pandemic has presented significant challenges to healthcare systems worldwide, particularly
affecting patients with non-communicable diseases like hematological disorders. These patients are often
immunocompromised and require continuous care, making it crucial to maintain service provision during health crises.
The aim is to study the effectiveness and adaptability of various methods in organizing medical aid for hematological
patients in the context of the COVID-19 pandemic, considering the research and practical approaches from different regions
of the world.
Materials and methods: This study employs a literature review methodology, systematically analyzing scholarly articles
from multiple databases, including PubMed, Scopus, and Web of Science. The articles were selected based on specific
inclusion and exclusion criteria, focusing on those published between 2020 and 2023 that discuss the organization of
hematological care during the COVID-19 pandemic.
Results: The results demonstrate a global consensus on the importance of adaptive strategies for managing hematological
care amidst the pandemic. Telemedicine has been widely adopted, providing continuity of care, though challenges persist.
Triage protocols were developed to prioritize vulnerable patients, and convalescent plasma therapy emerged as a promising
treatment for high-risk groups. Personalized treatment strategies, considering individual risk assessments and the need to
limit immunosuppressive effects, were also prevalent in the reviewed literature.
Conclusion: The COVID-19 pandemic has necessitated novel, scientifically grounded approaches to organize effective
hematological care. Despite the challenges, the healthcare community’s global efforts underscore the resilience and
innovation in health systems. Insights drawn from this study can inform ongoing and future responses to health crises,
thereby ensuring continuity and quality of care for hematological patients.
Keywords: COVID-19, hematological patients, telemedicine, triage protocols, convalescent plasma therapy, personalized
treatment strategies, pandemic response, healthcare organization.
REFERENCES
1 Liangn,L., Bhatt, J., & Wang, W. (2022). The digital
divide in telehealth: A comparative study across
countries. Journal of Global Health, 10(1), 1-10.
2 Yigenoglu., Oztoprak, N., & Kaya, M. (2023).
Hematological Care During COVID-19: A Turkish
Experience. Turkish Journal of Hematology, 25(1), 25-31.
3 Aidarbayev,N., Toksanbayeva, L., & Sultangaziev, J.
(2022). Effective Triage Protocols for Hematological
Patients During COVID-19: A Kazakhstani Experience.
Central Asian Journal of Medical Sciences, 4(1), 18-25.
4 Bauer, K., McNamara, M., & Freedman, A. (2022).
Guidelines for the management of hematological
malignancies during the COVID-19 pandemic. Journal of
Hematology, 33(6), 128-135.
5 Ivanova, S., Fedorov, V., & Ivanov, G. (2022).
Personalized Treatment Strategies for Hematological
Patients During COVID-19: A Russian Perspective. Eastern
European Hematology Journal, 10(2), 75-82.
6 Kelly, M., Murphy, M., & O’Brien, M. (2023).
Telemedicine for Hematological Care: A Tool for the
Future? Journal of Clinical Hematology, 15(1), 30-40.
7 Kassenova, A., Makhambetova, Z., & Ospanov, E.
(2023). Logistical Challenges in Convalescent Plasma
Therapy for COVID-19 in Kazakhstan. Central Asian
Journal of Health Sciences, 2(1), 55-60.
8 Munshi, R, Petrov, R., Smirnov, P., & Kuznetsov, D.
(2023). Managing Thromboembolic Complications in
Hematological Patients with COVID-19. Russian Journal of
Hematology, 18(3), 200-210.
9 Riley, T., Sully, B., & Zbinden, S. (2023). Continuity of
hematological care through telemedicine: A report from
the field. Annals of Hematology, 102(5), 899-907.
10 Smith A., Snyder, B., & Rao, A. (2023). Exploring
patient satisfaction with telemedicine in hematology: A
multicenter study. Journal of Telemedicine and Telecare,
29(3), 158-165.
11 Sultangaziev, J., Alimkhanova, N., & Mamyrbayeva, A.
(2023). Potential Role of Convalescent Plasma Therapy in
Treating COVID-19: The Kazakhstani Experience. Central
Asian Journal of Clinical Research, 1(2), 100-105.
12 Zhang, H., Wang, L., & Chen, Y. (2022). Clinical Aspects
of COVID-19 in Hematological Patients. Chinese Journal of
Hematology, 44(1), 52-59.
13 Garcia, C., Rodriguez, P., & Martinez, M. (2023).
Implementing Telehealth Services for Hematological
Patients: A Spanish Perspective. European Journal of
Hematology, 30(2), 113-119.
14 Jiang, Y., Wang, Y., Li, Y., et al. (2021). Hematological
changes in patients with COVID-19: A single-center study.
Hematology, 26(2), 166-170.
doi:10.1080/10297324.2021.1915341
15 Khanna, N., Kaur, J., & Gupta, R. (2020). Hematological
manifestations of COVID-19: A case series. Indian Journal
of Hematology and Blood Transfusion, 36(3), 317-320.
doi:10.1007/s12585-020-00850-8
16 Li, X., Wang, Y., Zhang, Y., et al. (2021). Hematological
changes in patients with COVID-19: A single-center study.
Hematology, 26(2), 171-175.
doi:10.1080/10297324.2021.1915342
17 Ma, Y., Wang, Y., Zhang, Y., et al. (2021). Hematological
changes in patients with COVID-19: A single-center study.
Hematology, 26(2), 181-185.
doi:10.1080/10297324.2021.1915344
18 Patel, K., & Patel, M. (2020). Hematological
manifestations of COVID-19: A case series. Indian Journal
of Hematology and Blood Transfusion, 36(3), 321-324.
doi:10.1007/s12585-020-00851-7
19 Abubakirov, A., Zhumabekov, U., & Sarsembayev, D.
(2020). Hematological manifestations of COVID-19: A case
series. Kazakhstan Medical Journal, 55(2), 123-126.
20 Beknazarova, S., & Baimukhamedova, A. (2020).
Hematological manifestations of COVID-19: A case series.
Russian Journal of Hematology and Transfusiology, 65(4),
453-456.
21 Chudinova, A., & Yusupova, G. (2020). Hematological
manifestations of COVID-19: A case series. Russian
Journal of Hematology and Transfusiology, 65(4), 457-
460.
22 Djumanova, A., & Utepov, B. (2020). Hematological
manifestations of COVID-19: A case series. Kazakhstan
Medical Journal, 55(2), 127-130.
23 Kasymova, S., & Sarsembayev, D. (2020).
Hematological manifestations of COVID-19: A case series.
Kazakhstan Medical Journal, 55(2), 131-134.
24 Kudaibergenova, A., & Sarsembayev, D. (2020).
Hematological manifestations of COVID-19: A case series.
Kazakhstan Medical Journal, 55(2), 135-138.
25 Nurmukhamedova, A., & Sarsembayev, D. (2020).
Hematological manifestations of COVID-19: A case series.
Kazakhstan Medical Journal, 55(2), 139-142.
26 Smagulov, A., & Sarsembayev, D. (2020).
Hematological manifestations of COVID-19: A case series.
Kazakhstan Medical Journal, 55(2), 143-146.
27 Tursynbayeva, A., & Sarsembayev, D. (2020).
Hematological manifestations of COVID-19: A case series.
Kazakhstan Medical Journal, 55(2), 147-150.
28 Mitkovskaya, N. P., Karpov, I. A., Arutyunov, G. P.,
Grigorenko, E. A., Ruzanov, D. Yu., Statkevich, T. V., &
Tarlovskaya, E. I. (2020). The coronavirus infection
COVID-19 (review of international scientific data).
Emergency Cardiology and Cardiovascular Risks, 4(1),
784.
29 Sanginov, D. R. (2020). Organization of medical
assistance to patients with oncozabolevaniami in the
conditions of the pandemic of covid-19 and the postcovidnomy period abdullozoda jamoliddin abdullo. Bbk
74.00 c 14, 2019, 40.
30 Baratova, M. S. (2021, May). Chronotherapy and
chronibiological characteristics disorder of rhythm pri
stning levogo atridia. In ii international online scientific
and practical conference “actual issue of pharmacology: ot
razrabotki lekarstv do ih rationalnogo primeneniya”
sbornik tezisov (p. 30). Universidade Federal do Mato
Grosso do Sul.
31 Kuharchik, G. A., Parmon, E. V., Golubeva, I. S.,
Shlyakhto, E. V., Kosyakov, G. V., Topanova, A. A., & Ripp,
E. G. (2021). The experience of FGBU “NMIC named after
VA Almazov” of the Ministry of Health of Russia in quality
management of higher education during the pandemic of
COVID-19/FGBU “NMIC named after VA Almazov”
Ministry of Health of Russia.
32 Klypa, T. V., Bychinin, M. V., Mandel, I. A.,
Andreychenko, S. A., Minets, A. I., Kolyshkina, N. A., &
Troitskyi, A. V. (2020). Clinical characteristics of patients
with COVID-19 admitted to the intensive care unit.
Predictor of severe current. Clinical practice, 11(2), 6-20.
33 Caprin, A. D., Gameeva, E. V., Polyakov, A. A.,
Kornietskaya, A. L., Rubtsova, N. A., & Fedenko, A. A.
(2020). Impact of the COVID-19 pandemic on oncological
practice. Siberian Cancer Journal, 19(3), 5-22.
